US Patent 9353176 Method of treating osteoarthritis with an antibody to NGF
Patent 9353176 was granted and assigned to Regeneron Pharmaceuticals on May, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 1 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+342 characters)
Article
Patent abstract
Methods are disclosed for treating osteoarthritis in a human subject in need thereof, comprising administering to the subject a therapeutically effective amount of an anti-human NGF antibody, or antigen-binding fragment thereof, wherein at least one symptom associated with osteoarthritis is prevented, ameliorated or improved.
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Joel C. Reinhardt0
Joel H. Martin0
Lynn MacDonald0
Marc R. Morra0
Paul Tiseo0
Richard Torres0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09353176 Method of treating osteoarthritis with an antibody to NGF US Patent 9353176 Method of treating osteoarthritis with an antibody to NGF
Infobox
Patent Number
09353176
Patent Number
9353176
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09353176 Method of treating osteoarthritis with an antibody to NGF
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09353176
Date of patent
May 31, 2016
Patent application number
14038349
Date Filed
September 26, 2013
Patent primary examiner
Find more entities like US Patent 9353176 Method of treating osteoarthritis with an antibody to NGF
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
